Editor,—We read with interest the report by Bansi and colleagues ((2000) Gut 46:283–285; OpenUrlPubMedWeb of Science) describing fibrosing colonopathy secondary to high dose pancreatic enzyme therapy in an adult patient. Some details of the patient's history—cholangitis, pancreatitis, and pancreatic insufficiency—are strikingly similar to symptoms displayed by our adult patient with cystic fibrosis and fibrosing colonopathy described previously.1 In this patient with cystic fibrosis, chronic cholangitis …